ArticleDrug design, development and therapy2026

GBVAM as a Novel NHE1 Inhibitor Alleviates Doxorubicin-Induced Cardiotoxicity via PI3K/Akt/mTOR Pathway.

Yunsheng Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.